<DOC>
	<DOC>NCT00539890</DOC>
	<brief_summary>To compare the efficacy of prandial TI plus basal insulin versus prandial rapid acting, subcutaneous insulin plus basal insulin in subjects with type 2 diabetes who had an HbA1c &gt;7.0% and &lt;11.5%.</brief_summary>
	<brief_title>Comparison Between Technosphere/Insulin Inhalation Powder Versus Rapid Acting Insulin in Subjects With Type 2 Diabetes Mellitus</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<mesh_term>Insulin, Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin, Short-Acting</mesh_term>
	<criteria>At least 2 years since diagnosis of type 2 diabetes mellitus Received subcutaneous (sc) insulin for at least 3 months Body Mass Index &lt;44 kg/m2 HbA1c&gt;7.0% and &lt;11.5% Serum creatinine &lt;2.0 mg/dL for males and &lt;1.8 mg/dL for females Baseline FVC and FEV1&gt;70% and &lt; 125% of predicted normal Significant hepatic disease (AST/ALT3 x ULN) Diagnosis of Type 1 diabetes Severe complications of diabetes History of moderate to severe ketoacidosis within the past 3 months Upper respiratory infection in the last 15 days or a lower respiratory infection in the past 30 days Diagnosis of HIV Positive serology for hepatitis B or C COPD, emphysema, or asthma Current smokers or smoking history within the past 6 months Major psychiatric disorder precluding satisfactory completion of protocol Clinically significant heart disease disease, stroke or heart attack within the past 6 months Treatment with an investigational drug within 30 days Previous treatment with Technosphere/Insulin History of malignancy in the past 5 years except basal cell carcinoma Anemia (hemoglobin &lt;10.5 g/dL for females and &lt;11.5 g/dL (for males) Women who were pregnant of lactating History of hypersensitivity to drugs resembling FDKP carrier products Treatment with another inhaled insulin product during the duration of the study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2009</verification_date>
</DOC>